3 glp 1 drugs Comparing Ozempic, Wegovy and Other GLP-1 Blockbuster GLP-1 Diabetes and Weight

These effects limited EMT and invasive behavior (Zhao et al., 2014)

bariatric procedure volumes declined 11.4% in 2025 reversing a two-decade growth trend as semaglutide and tirzepatide provide comparable weight loss outcomes for class I and class II obesity without surgical risk, recovery time, or nutritional deficiency complications

The phase IIIb clinical trial directly comparing both medications (SURMOUNT-5) is ongoing [38]

Obesity 31 , 21712177 (2023)

[24] [25] These laboratory findings suggest potential protective mechanisms, though their clinical relevance in humans remains uncertain

These findings suggest that, in addition to its role in modulating immune responses, exenatide confers neuroprotection by alleviating ER stress, thus preserving cellular integrity and supporting functional recovery